News News Select Year All Years 2026 (23) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 495 Results Page 49 of 50« First«...102030...4647484950» June 8, 2011 DBV Technologies VIASKIN® technology has been chosen to feature on the cover of the European Journal of Allergy and Clinical Immunology June 2011 issue in its timeline “100 years allergen specific immunotherapy.” January 18, 2011 DBV Technologies elects George Horner as non executive Chairman January 8, 2011 DBV Technologies is very proud to have been chosen to feature on the cover of the Journal of Allergy and Clinical Immunology January 2011 issue January 5, 2011 DBV Technologies closes $25.5 (€19,4) million Series ‘C’ financing round September 23, 2010 DBV Technologies Granted US Patents for Allergen Delivery System VIASKIN® September 1, 2010 VIASKIN® PEANUT Selected for U.S. Consortium of Food Allergy Research’s Peanut Allergy Desensitization Trial July 6, 2010 DBV Technologies Receives IND Clearance From FDA to Begin Clinical Trial in Peanut Allergy June 14, 2010 DBV Technologies expands Scientific Advisory Board with appointment of leading US allergy specialists December 18, 2009 DBV Technologies appoints Professor Robert Zeiger to its Scientific Advisory Board October 19, 2009 DBV Technologies appoints Professors Gideon Lack and Philippe Eigenmann to its Scientific Advisory Board Page 49 of 50« First«...102030...4647484950»